Suspended

Clinical trial suspensions rocket in the wake of Covid-19

An across-the-board clinical trial registry analysis spells out the effect of measures to slow the spread of the new coronavirus.

Biotech’s balancing act amid Covid-19 delays

A Vantage analysis suggests which small biotechs might seriously have to rethink R&D spending plans in the wake of Covid-19.

December 19, 2019

Gene therapy clinical holds take centre stage

An analysis of company disclosures reveals a sharp rise in US FDA-imposed halts on clinical work involving gene therapies.

June 19, 2018

Ziopharm stalls its CAR yet again

May 29, 2018

Another checkpoint combo blow-up fuels Darzalex doubts

April 24, 2018

Accelerated filing delay could be the least of Epizyme’s problems

April 10, 2018

Quiet Modul halt puts the pressure on Exelixis

March 29, 2018

Snippet roundup: Edge blunted by trial's end, but Esperion soars on bempedoic acid hopes

March 06, 2018

Cell therapy flotations could follow Kite and Juno buyouts

February 09, 2018

Sarepta contains UK study halt, for now

January 31, 2018

Bellicum’s cells not so controllable after all

Load More